ArticleJournal of neuroscience research2016

Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.

Dae Song Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.